GlassScriptPhysician profile
James A Watkins
NPI 1023009321
$883.47
in general payments reported to CMS, 2019-2025
8 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $131 · 2023: $300 · 2024: $127 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $358.91 | 2022-2025 | Puraply, Apligraf, Affinity |
| Smith+Nephew, INC. | $329.76 | 2021-2023 | Collagenase Santyl, Oasis, Grafix Pl |
| Tactile Systems Technology INC | $89.57 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Molnlycke Health Care US, LLC | $32.76 | 2022-2023 | Exufiber Ag+, Mepilex Border Flex, Mepilex Border Post-Op |
| Next Science LLC | $23.83 | 2024 | Surgx, Blastx, Xperience |
| Medline Industries LP | $20.00 | 2022 | |
| Coloplast Corp | $14.97 | 2025 | |
| Medtronic, INC. | $13.67 | 2024 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.